Butyric acid derivative induces allospecific T cell anergy and prevents graft-versus-host disease

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 1, 2003, Pages 13-27

  Gilbert, Kathleen M ^a   Boger, Susan ^a   Fifer, E Kim ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID DERIVATIVE;

ALLOIMMUNITY; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW TRANSPLANTATION; CYTOKINE RELEASE; DRUG EFFECT; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE ACTIVATION; MALE; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPLEEN CELL; SPLENOMEGALY; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; BUTYRATES; CELL TRANSPLANTATION; CELLS, CULTURED; CLONAL ANERGY; CYTOKINES; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; ISOANTIGENS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MORPHOLINES; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0037234929     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120018280     Document Type: Article

References (27)

1. Gilbert, K.M.; Fecher, N.; Wahid, R.; Fifer, E.K. Potential clinical use of butyric acid derivatives to induce antigen-specific T cell inactivation. J. Pharmacol. Exp. Ther. 2000, 294, 1146-1153.
2. Gilbert, K.M.; Weigle, W.O. Th1 cell anergy and blockade in G1a phase of the cell cycle. J. Immunol. 1993, 151, 1245-1254.
3. KiP1. J. Immunol. 2001, 166, 952-958.
4. Ho, V.T.; Soiffer, R.J. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001, 98, 3194-3204.
5. Gleichmann, E.; Pals, S.T.; Rolink, A.G.; Radaszkiewicz, T.; Gleichmann, H. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 1984, 5, 324-328.
6. Jackson, S.K.; DeLoose, A.; Gilbert, K.M. The ability of antigen, but not IL-2, to promote n-butyrate-induced Th1 cell anergy is associated with increased expression and altered association patterns of cyclin dependent kinase inhibitors. Immunology 2002, In press.
7. Salomon, D.R.; Cohen, D.J.; Williams, J.M.; Carpenter, C.B. T cell synergy in the primary MLR: proliferative kinetics, effector cell generation, and IL 2 production. J. Immunol. 1984, 133, 3075-3083.
8. Croft, M.; Joseph, S.B.; Miner, K.T. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells. J. Immunol. 1997, 159, 3257-3265.
9. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β. J. Immunol. 1999, 163, 3684-3691.
10. Jenkins, M.K.; Chen, C.; Jung, G.; Mueller, D.L.; Schwartz, R.H. Inhibition of antigen-specific proliferation of type murine T cell clones afer stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 1990, 144, 16-22.
11. Jenkins, M.K.; Pardoll, D.M.; Mizuguchi, J.; Chused, T.M.; Schwartz, R.H. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl Acad. Sci. USA 1987, 84, 5409-5413.
12. Sloan-Lancaster, J.; Evavold, B.D.; Allen, P.M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993, 363, 156-159.
13. Quill, H.; Schwartz, R.H. Stimulation of normal inducer T cell clones with antigen presented by purified la molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness J. Immunol. 1987, 138, 3704-3704.
14. Li, B.; New, J.Y.; Yap, E.H.; Lu, J.; Chan, S.H.; Hu, H. Blocking L-selection and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease. Eur. J. Immunol. 2001, 31, 617-624.
15. Bathe, O.F.; Dalyot-Herman, N.; Malek, T.R. IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells. J. Immunol. 2001, 167, 4511-4517.
16. Aparicio, C.L.; Berthiaume, F.; Chang, C.C.; Yarmush, M.L. Tumor necrosis factor-alpha (TNF-alpha) induces a reversible, time- and dose-dependent adhesion of progenitor T cells to endothelial cells. Mol. Immunol. 1996, 33, 671-680.
17. Yang, Y.G.; Qi, J.; Wang, M.G.; Sykes, M. Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood 2002, 99, 4207-4215.
18. Hill, G.R.; Teshima, T.; Rebel, V.I.; Krijanovski, O.I.; Cooke, K.R.; Brinson, Y.S.; Ferrara, J.L. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. J. Immunol. 2002, 164, 656-663.
19. Garside, P.; Bunce, C.; Tomlinson, R.C.; Nichols, B.L.; Mowat, A.M. Analysis of enteropathy induced by tumor necrosis factor alpha. Cytokine 1993, 5, 24-30.
20. del Rosario, M.L.; Zucali, J.R.; Kao, K.J. Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor. Blood 1999, 93, 3558-3564.
21. Chen, B.J.; Chen, Y.; Cui, X.; Fidler, J.M.; Chao, N.J. Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model. Transplantation 2002, 73, 115-121.
22. +T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody. J. Immunol. 2000, 164, 612-622.
23. Kaminski, E.; Hows, J.; Man, S.; Brookes, P.; Mackinnon, S.; Hughes, T.; Avakian, O.; Goldman, J.M.; Batchelor, J.R. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 1989, 48, 608-613.
24. Go, C.; Lancki, D.W.; Fitch, F.W.; Miller, J. Energized T cell clones retain their cytolytic ability. J. Immunol. 1993, 2, 367-376.
25. +T cell: receptor-dependent cytolysis in the absence of interluekin-2 production. Science 1991, 251, 1228-1232.
26. Hollsberg, P.; Batra, V.; Dressel, A.; Hafler, D.A. Induction of anergy in CD8 T cells by B cell presentation of antigen. J. Immunol. 1996, 157, 5269-5276.
27. Tan, P.; Anasetti, C.; Hansen, J.A.; Melrose, J.; Brunvand, M.; Bradshaw, J.; Ledbetter, J.A.; Linsley, P.S. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 1993, 177, 165-173.